Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of Envoy Medical, Inc. (“Envoy” or the “Company”) (NASDAQ: COCH). Such investors are advised to contact...
-
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of Golden Heaven Group Holdings Ltd. (“Golden Heaven” or the “Company”) (NASDAQ: GDHG). Such investors...
-
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of BlackRock, Inc. (“BlackRock” or the “Company”) (NYSE: BLK). Such investors are advised to contact...
-
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of Amtech Systems, Inc. (“Amtech” or the “Company”) (NASDAQ: ASYS). Such investors are advised to...
-
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of Hywin Holdings Ltd. (“Hywin” or the “Company”) (NASDAQ: HYW). Such investors are advised to contact...
-
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (NASDAQ: CKPT). Such investors are...
-
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT). Such investors are...
-
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Entrada Therapeutics, Inc. (“Entrada” or the “Company”) (NASDAQ: TRDA). Such investors...
-
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Legend Biotech Corporation (“Legend” or the “Company”) (NASDAQ: LEGN). Such investors are...
-
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Palantir Technologies Inc. (“Palantir” or the “Company”) (NYSE: PLTR). Such investors are...